Patent policy in a world where most patents are worthless

被引：0

|

作者：

Motsenbocker, M.

Druce, N.

机构：

来源：

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2006年 / 2卷 / 04期

关键词：

D O I：

10.1016/j.nano.2006.10.064

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

引用

收藏

页码：282 / 282

页数：1

相关论文

共 50 条

[31] True Patent Value: Defining Quality in Patents and Patent Portfolios
Factor, Michael
JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2014, 9 (02) : 168 - 169
[32] PATENTS AS INFORMATION-TRANSFER MECHANISMS - TO PATENT OR (MAYBE) NOT TO PATENT
HORSTMANN, I
MACDONALD, GM
SLIVINSKI, A
JOURNAL OF POLITICAL ECONOMY, 1985, 93 (05) : 837 - 858
[33] Patents and public health in France. Pharmaceutical patent law in-the-making at the patent office between the two world wars
Cassier, Maurice
History and Technology, 2008, 24 (02) : 135 - 151
[34] Where the Most Private Becomes Public: Policy Making for Sexual Health
不详
PLOS MEDICINE, 2009, 6 (05)
[35] Basic of US patents and the patent system
George Elliott
The AAPS Journal, 9
[36] Basics of US patents and the patent system
Elliott, George
AAPS JOURNAL, 2007, 9 (03): : E317 - E324
[37] PATENTS AND PATENT OFFICE RESOURCES IN BIOTECHNOLOGY
KONIAREK, JP
COLEMAN, KD
BIOTECHNIQUES, 1988, 6 (02) : 148 - 153
[38] Patent office treatment of financial patents
Schreiner, Stephen
BANKING LAW JOURNAL, 2006, 123 (07): : 660 - 664
[39] European patents Vegetable patent appeals
O'Driscoll, Cath
CHEMISTRY & INDUSTRY, 2010, (15) : 6 - 6
[40] Patents: Biotechnology patent applications in Europe
de, Looze, Marie Angele
Ramani, Shyama V.
Nature Biotechnology, 1999, 17 (01):

← 1 2 3 4 5 →